(Applicant?s Description) The H. Lee Moffitt Cancer Center requests renewal of its National Cancer Institute (NCI) Center Core Support Grant (CCSG) for years 4-8 and designation as a Comprehensive Cancer Center. The Center has continued its remarkable growth, nearly doubling both its NCI and total peer reviewed funding during the first two years of the CCSG. The Center has added nearly 50,000 sq ft of new research space and will add another 200,000 sq ft of new research space in 2003. All of the commitments to the growth of the Center and its scientific staff will allow it to achieve its sole mission of """"""""contributing to the prevention and cure of cancer."""""""" As one of only a handful of freestanding centers located on a university campus, the Moffitt Cancer Center enjoys the benefits of being freestanding within the intellectual arena of a university based matrix center. In addition, the Center benefits from extraordinary support from the State of Florida, the University of South Florida and its own Board of Directors. The Center, which brings together all clinical and research approaches to cancer at the University of South Florida under one management structure, seeks support for four scientific programs, 11 shared resources, seven staff investigators, developmental funds and administration. In 1997, the Cancer Center asked the site reviewers to recognize the Center?s potential to become a major NCI designated cancer center and contributor to the national cancer research program. The Moffitt Cancer Center has remained true to that commitment and seeks to expand upon it.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA076292-07S2
Application #
6938012
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1998-02-19
Project End
2006-01-31
Budget Start
2004-02-01
Budget End
2005-01-31
Support Year
7
Fiscal Year
2004
Total Cost
$175,000
Indirect Cost
Name
University of South Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
069687242
City
Tampa
State
FL
Country
United States
Zip Code
33612
Karolak, Aleksandra; Rejniak, Katarzyna A (2018) Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue. Bull Math Biol :
Karolak, Aleksandra; Estrella, Veronica C; Huynh, Amanda S et al. (2018) Targeting Ligand Specificity Linked to Tumor Tissue Topological Heterogeneity via Single-Cell Micro-Pharmacological Modeling. Sci Rep 8:3638
Barata, Anna; Gonzalez, Brian D; Sutton, Steven K et al. (2018) Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatology. J Health Psychol 23:1028-1037
Li, Qian; Balagurunathan, Yoganand; Liu, Ying et al. (2018) Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial. Clin Lung Cancer 19:148-156.e3
Kazi, Aslamuzzaman; Xiang, Shengyan; Yang, Hua et al. (2018) GSK3 suppression upregulates ?-catenin and c-Myc to abrogate KRas-dependent tumors. Nat Commun 9:5154
McWilliams, Robert R; Wieben, Eric D; Chaffee, Kari G et al. (2018) CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. Cancer Epidemiol Biomarkers Prev 27:1364-1370
Ctortecka, Claudia; Palve, Vinayak; Kuenzi, Brent M et al. (2018) Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells. Mol Cell Proteomics 17:2434-2447
Ferreiro-Iglesias, Aida; Lesseur, Corina; McKay, James et al. (2018) Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nat Commun 9:3927
Schmit, Stephanie L; Edlund, Christopher K; Schumacher, Fredrick R et al. (2018) Novel Common Genetic Susceptibility Loci for Colorectal Cancer. J Natl Cancer Inst :
Kang, Sokbom; Thompson, Zachary; McClung, E Claire et al. (2018) Gene Expression Signature-Based Prediction of Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer. Int J Gynecol Cancer 28:260-266

Showing the most recent 10 out of 1254 publications